Loracarbef
Alternative Names: KT 3777; Lorabid; Lorafem; Lorbef; LY 163892Latest Information Update: 24 Oct 2021
At a glance
- Originator Kyowa Hakko
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bacterial infections
Most Recent Events
- 01 Mar 2011 King Pharmaceuticals has been acquired and merged into Pfizer
- 10 Apr 1996 Phase-III clinical trials for Bacterial infections in Japan (PO)
- 14 Mar 1996 Registered for Bacterial infections in Canada (PO)